Halozyme Therapeutics
HALO
#2125
Rank
A$11.68 B
Marketcap
$94.91
Share price
2.51%
Change (1 day)
55.40%
Change (1 year)

Halozyme Therapeutics (HALO) - Cash on Hand

Cash on Hand as of December 2024 : A$0.95 Billion

According to Halozyme Therapeutics's latest financial reports the company has A$0.95 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Halozyme Therapeutics - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.49 B-7.49%
2022-12-31A$0.53 B-47.83%
2021-12-31A$1.02 B113.54%
2020-12-31A$0.47 B-20.46%
2019-12-31A$0.60 B19.56%
2018-12-31A$0.50 B-16.27%
2017-12-31A$0.60 B111.35%
2016-12-31A$0.28 B91.22%
2015-12-31A$0.14 B-10.26%
2014-12-31A$0.16 B106.73%
2013-12-31A$80.16 M-16.28%
2012-12-31A$95.74 M85.85%
2011-12-31A$51.51 M-37.14%
2010-12-31A$81.96 M9.14%
2009-12-31A$75.1 M-16.84%
2008-12-31A$90.31 M-19.17%
2007-12-31A$0.11 B99.31%
2006-12-31A$56.05 M114.39%
2005-12-31A$26.14 M26.4%
2004-12-31A$20.68 M2953.29%
2003-12-31A$0.67 M292.5%
2002-12-31A$0.17 M237.17%
2001-12-31A$0.05 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.40 B-57.79%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.49 B 474.29%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.27 B 138.23%๐Ÿ‡บ๐Ÿ‡ธ USA
A$15.96 B 1,569.59%๐Ÿ‡บ๐Ÿ‡ธ USA
A$13.23 B 1,283.88%๐Ÿ‡ซ๐Ÿ‡ท France
A$39.34 B 4,013.92%๐Ÿ‡บ๐Ÿ‡ธ USA